Embryonic stem cell-based cardiopatches improve cardiac function in infarcted rats

Stem Cells Translational Medicine

Volumn 1, Issue 3, 2012, Pages 248-260

  Vallée, Jean Paul ^a   Hauwel, Mathieu ^b   Lepetit Coiffée, Matthieu ^a   Bei, Wang ^b   Montet Abou, Karin ^a   Meda, Paolo ^b   Gardier, Stephany ^a   Zammaretti, Prisca ^b   Kraehenbuehl, Thomas P ^b   Herrmann, Francois ^a   Hubbell, Jeffrey A ^c   Jaconi, Marisa E ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c EPFL   (Switzerland)

Author keywords

Cardiac; Embryonic stem cells; Stem cell transplantation; Tissue regeneration

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CD31 ANTIGEN; MYOCYTE ENHANCER FACTOR 2; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; ELECTRON MICROSCOPY; EMBRYONIC STEM CELL; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE MASS; HISTOLOGY; IMMUNOHISTOLOGY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; STEM CELL TRANSPLANTATION; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; ENZYME IMMUNOASSAY; HEART; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HEART; IMMUNOENZYME TECHNIQUES; MAGNETIC RESONANCE IMAGING; MALE; MICE; MYOCARDIAL INFARCTION; RATS; STEM CELL TRANSPLANTATION;

EID: 84865969213     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2011-0028     Document Type: Article

References (64)

1. Thom T, Haase N, Rosamond W et al. Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-e151.
2. Anversa P, Leri A, Kajstura J. Cardiac regeneration. J Am Coll Cardiol 2006;47:1769-1776.
3. Parmacek MS, Epstein JA. Cardiomyocyte renewal. N Engl J Med 2009;361:86-88.
4. Schuleri KH, Amado LC, Boyle AJ et al. Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol 2008;294:H2002-H2011.
5. Terrovitis J, Bulte J, Sarvananthan S et al. Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells seeded on collagen scaffolds-relevance to tissue engineering. Tissue Eng 2006;12:2765-2775.
6. Ye Y, Bogaert J. Cell therapy in myocardial infarction: Emphasis on the role of MRI. Eur Radiol 2008;18:548-569.
7. Flynn A, O'Brien T. Stem cell therapy for cardiac disease. Expert Opin Biol Ther 2011;11: 177-187.
8. Qiao H, Zhang H, Yamanaka S et al. Longterm improvement in postinfarct left ventricular global and regional contractile function is mediated by embryonic stem cell-derived cardiomyocytes. Circ Cardiovasc Imaging 2011;4: 33-41.
9. Kraehenbuehl TP, Ferreira LS, Hayward AM et al. Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials 2011;32:1102-1109.
10. Carr CA, Stuckey DJ, Tan JJ et al. Cardiosphere-derived cells improve function in the infarcted rat heart for at least 16 weeks-an MRI study. PLoS One 2011;6:e25669.
11. Au KW, Liao SY, Lee YK et al. Effects of iron oxide nanoparticles on cardiac differentiation of embryonic stem cells. Biochem Biophys Res Commun 2009;379:898-903.
12. Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration. Circ Res 2002;91: 1092-1102.
13. Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature 2008;453:322-329.
14. Joggerst SJ, Hatzopoulos AK. Stem cell therapy for cardiac repair: Benefits and barriers. Expert Rev Mol Med 2009;11:e20.
15. Rangappa S, Makkar R, Forrester J. Review article: Current status of myocardial regeneration: New cell sources and new strategies. J Cardiovasc Pharmacol Ther 2010;15: 338-343.
16. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature 2008;451:937-942.
17. Laflamme MA, Murry CE. Heart regeneration. Nature 2011;473:326-335.
18. Laflamme MA, Chen KY, Naumova AV et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007;25:1015-1024.
19. Suter DM, Cartier L, Bettiol E et al. Rapid generation of stable transgenic embryonic stem cell lines using modular lentivectors. STEM CELLS 2006;24:615-623.
20. Freund C, Mummery CL. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. J Cell Biochem 2009;107:592-599.
21. Mooney DJ, Vandenburgh H. Cell delivery mechanisms for tissue repair. Cell Stem Cell 2008;2:205-213.
22. Gaballa M, Sunkomat J, Thai H et al. Grafting an acellular 3-dimensional collagen scaffold onto a non-transmural infarcted myocardium induces neo-angiogenesis and reduces cardiac remodeling. J Heart Lung Transplant 2006;25:946-954.
23. Leor J, Gerecht-Nir S, Cohen S et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 2007;93: 1278-1284.
24. Zimmermann WH, Melnychenko I, Wasmeier G et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006;12: 452-458.
25. Christman KL, Lee RJ. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 2006;48:907-913.
26. Caspi O, Lesman A, Basevitch Y et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 2007;100:263-272.
27. Lesman A, Habib M, Caspi O et al. Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng Part A 2010;16:115-125.
28. Kraehenbuehl TP, Langer R, Ferreira LS. Three-dimensional biomaterials for the study of human pluripotent stem cells. Nat Methods 2011;8:731-736.
29. Shimizu T, Yamato M, Isoi Y et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 2002;90:e40.
30. Miyahara Y, Nagaya N, Kataoka M et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006;12:459-465.
31. Vacanti JP, Langer R, Upton J et al. Transplantation of cells in matrices for tissue regeneration. Adv Drug Deliv Rev 1998;33: 165-182.
32. Zammaretti P, Jaconi M. Cardiac tissue engineering: Regeneration of the wounded heart. Curr Opin Biotechnol 2004;15:430-434.
33. Dai W, Wold LE, Dow JS et al. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: A novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol 2005; 46:714-719.
34. Christman KL, Vardanian AJ, Fang Q et al. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 2004;44:654-660.
35. Zimmermann WH. Tissue engineering: Polymers flex their muscles. Nat Mater 2008;7: 932-933.
36. Engelmayr GC, Jr., Cheng M, Bettinger CJ et al. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater 2008;7:1003-1010.
37. Davis ME, Hsieh PC, Grodzinsky AJ et al. Custom design of the cardiac microenvironment with biomaterials. Circ Res 2005;97:8-15.
38. Ehrbar M, Djonov VG, Schnell C et al. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res 2004;94:1124-1132.
39. Urech L, Bittermann AG, Hubbell JA et al. Mechanical properties, proteolytic degradability and biological modifications affect angiogenic process extension into native and modified fibrin matrices in vitro. Biomaterials 2005; 26:1369-1379.
40. He Q, Trindade PT, Stumm M et al. Fate of undifferentiated mouse embryonic stem cells within the rat heart: Role of myocardial infarction and immune suppression. J Cell Mol Med 2009;13:188-201.
41. Li J, Stouffs M, Serrander L et al. The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activation. Mol Biol Cell 2006;17:3978-3988.
42. Ménard C, Hagege AA, Agbulut O et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: A preclinical study. Lancet 2005;366: 1005-1012.
43. Meyer N, Jaconi M, Landopoulou A et al. A fluorescent reporter gene as a marker for ventricular specification in ES-derived cardiac cells. FEBS Lett 2000;478:151-158.
44. Kraehenbuehl TP, Zammaretti P, Van der Vlies AJ et al. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: Systematic modulation of a synthetic cellresponsive PEG-hydrogel. Biomaterials 2008; 29:2757-2766.
45. Reynolds ES. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 1963;17:208-212.
46. Ivancevic M, Daire J, Hyacinthe J et al. High-resolution complementary spatial modulation of magnetization (CSPAMM) rat heart tagging on a 1.5 Tesla Clinical Magnetic Resonance System: A preliminary feasibility atudy. Invest Radiol 2007;42:204-210.
47. Daire J, Hyacinthe J, Tatar I et al. In vivo myocardial infarct area at risk assessment in the rat using manganese enhanced magnetic resonance imaging (MEMRI) at 1.5T. Magn Reson Med 2008;59:1422-1430.
48. Daire J, Jacob J, Hyacinthe J et al. Cine and tagged MRI in normal rat at 1.5T: A rest and stress study. J Cardiovasc Magn Reson 2008;10:48.
49. Jacob J, Vachier C, Morel J et al. Extrema temporal chaining: A new method for computing the 2D-displacement field of the heart from tagged MRI. Lect Notes Comput Sci 2006;4179: 897-908.
50. Lendrum AC, Fraser DS, Slidders W et al. Studies on the character and staining of fibrin. J Clin Pathol 1962;15:401-413.
51. Chaudeurge A, Wilhelm C, Chen-Tournoux A et al. Can magnetic targeting of magnetically labeled circulating cells optimize intramyocardial cell retention? Cell Transplantation 2011 [Epub ahead of print].
52. van Laake LW, Passier R, den Ouden K et al. Improvement of mouse cardiac function by hESC-derived cardiomyocytes correlates with vascularity but not graft size. Stem Cell Res 2009;3:106-112.
53. Stuckey DJ, Ishii H, Chen QZ et al. Magnetic resonance imaging evaluation of remodeling by cardiac elastomeric tissue scaffold biomaterials in a rat model of myocardial infarction. Tissue Eng Part A 2010;16:3395-3402.
54. Terrovitis J, Stuber M, Youssef A et al. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 2008; 117:1555-1562.
55. Corot C, Robert P, Idee JM et al. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006; 58:1471-1504.
56. Ris F, Lepetit-Coiffe M, Meda P et al. Assessment of human islet labeling with clinical grade iron nanoparticles prior to transplantation for graft monitoring by MRI. Cell Transplant 2010;19:1573-1585.
57. Ye Z, Zhou Y, Cai H et al. Myocardial regeneration: Roles of stem cells and hydrogels. Adv Drug Deliv Rev 2011;63:688-697.
58. van Laake LW, Passier R, Doevendans PA et al. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res 2008;102:1008-1010.
59. Behfar A, Zingman LV, Hodgson DM et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 2002;16:1558-1566.
60. Hodgson DM, Behfar A, Zingman LV et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 2004;287:H471-H479.
61. Raida M, Clement JH, Leek RD et al. Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. J Cancer Res Clin Oncol 2005;131:741-750.
62. Cao F, van der Bogt KE, Sadrzadeh A et al. Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. Stem Cells Dev 2007;16:883-891.
63. Nussbaum J, Minami E, Laflamme MA et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB J 2007;21:1345-1357.
64. Bolli R, Chugh AR, D'Amario D et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial. Lancet 2011;378: 1847-1857.